Earnings · China A-shares
Runben Biotechnology Co Ltd. Class A (603193) earnings
Runben Biotechnology Co Ltd. Class A published its Q3 report on 2026-10-19: net profit +12.79% year on year, +15.87% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -10.40% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-19
- Period end
- 2026-09-30
- Net profit YoY
- +12.79%
- Excl. one-offs YoY
- +15.87%
- Net profit QoQ
- -56.51%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -8.64% | — |
| 3 days | -10.40% | — |
| 7 days | -12.47% | — |
| 14 days | -12.07% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -0.16%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-20 | ¥300.09M | +12.79% | +15.87% | +13.63% | 0.74 | 12.91% | -10.40% | — | — |
| 2026 interim report | 2026-08-21 | ¥225.09M | +20.03% | +22.58% | +17.74% | 0.56 | 9.72% | -0.51% | -5.34% | +0.37% |
| 2026 Q1 report | 2026-04-23 | ¥52.64M | +19.09% | +25.14% | +11.27% | 0.13 | 2.34% | +8.14% | -11.72% | -10.16% |
| 2025 annual report | 2026-04-23 | ¥314.50M | +4.78% | +2.15% | +17.19% | 0.78 | 14.54% | +8.14% | -11.72% | -10.16% |
| 2025 Q3 report | 2025-10-21 | ¥266.05M | +1.98% | -1.79% | +19.28% | 0.66 | 12.25% | -5.48% | -8.76% | -9.26% |
| 2025 interim report | 2025-08-19 | ¥187.52M | +4.16% | +0.86% | +20.31% | 0.46 | 8.69% | -3.51% | -10.54% | -19.71% |
| 2025 Q1 report | 2025-04-25 | ¥44.20M | +24.60% | +22.85% | +44.00% | 0.11 | 2.10% | +10.78% | +3.44% | +0.19% |
| 2024 annual report | 2025-04-25 | ¥300.16M | +32.80% | +32.28% | +27.61% | 0.74 | 14.91% | +10.78% | +3.44% | +0.19% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.